Pharm Tech Minutes 2023.03.02: Difference between revisions
Jump to navigation
Jump to search
Michael tan (talk | contribs) |
Michael tan (talk | contribs) |
||
| Line 37: | Line 37: | ||
:** Geneva will contribute to this effort | :** Geneva will contribute to this effort | ||
:** Oliver Egger is willing to cooperate, but will not invest in IHE Pharmacy | :** Oliver Egger is willing to cooperate, but will not invest in IHE Pharmacy | ||
:** The government is thinking of enforcing regulations on the standards. | |||
:** | |||
:* IHE Europe | :* IHE Europe | ||
:** Should align with European efforts | :** Should align with European efforts | ||
| Line 44: | Line 47: | ||
:* IHE NL | :* IHE NL | ||
:** misses the users. But in the scope of pharmacy the users are still unaware of what they are missing. | :** misses the users. But in the scope of pharmacy the users are still unaware of what they are missing. | ||
:** Netherlands do have a legal track called Wegiz. This could also lead to opportunities for Pharmacy. | |||
:** Marc looks at the different European countries. Dedalus would like to have one integrated set of profiles, because now they have to conform to different flavors at this moment. | |||
Revision as of 05:31, 2 March 2023
Minutes
Meeting Venue
- Oude Middenweg 55
- 2491 AC Den Haag
- Virtual meeting room : Teams
10:00 Welcome, planning, approve agenda
- Participants
-
- Tie Tjee IHE NL vendor co-chair
- Sylvia Stein GS1
- Hernany Silva Costa Melo Nictiz
- Michael Tan Woxingtan
- Jose Costa Teixeira Path
- Stephane Spahni Univ.hospital Geneva
- Ruth Lindstrom ( Estonia)
- Anne van Berkel Meier GS1 (on line)
- Leonidas Tzimis EAHP( on line)
- Sofia Franconi ( on line)
- Marc Robberecht Dedalus (on line)
- Alexander Berler ( IHE Europe)
Agenda topics:
- Reflection of organizations of the involved parties on the role of IHE Pharmacy
- Switzerland
- FHIR has resources but they are too much optionality.
- IHE Pharmacy should reduce the resources.
- Geneva will contribute to this effort
- Oliver Egger is willing to cooperate, but will not invest in IHE Pharmacy
- The government is thinking of enforcing regulations on the standards.
- IHE Europe
- Should align with European efforts
- Focus on tracks where Connectathons could help with testing and certifying interoperability
- For example Unicom. Should have a demonstration in September at the Connectathons in Rennes
- Gravitate project. See how we can adjust available profiles in a testable profile.
- IHE NL
- misses the users. But in the scope of pharmacy the users are still unaware of what they are missing.
- Netherlands do have a legal track called Wegiz. This could also lead to opportunities for Pharmacy.
- IHE Europe
- Marc looks at the different European countries. Dedalus would like to have one integrated set of profiles, because now they have to conform to different flavors at this moment.
- Brief updates from ISO, HL7 (Logical models, FHIR releases)
- WHO Smart Guidelines and other work
- Refresh current work items / roadmap overview (5m)
- UNICOM (Alexander Berler & Sofia Franconi)
- eHDSI, Gravitate (ePI?) project, JA09
- Co-chair positions & elections, vacancy
- Secretary position and activities (open since Simon left)
- Call schedule (PATH can host future Teams calls)
- Update Planning of season 2022-2023
- Marketing and communication plan
- How to use the input of IHE international
- Financial topics of pharmacy (Sponsors)
- IHE and EU specification maintenance
- Repositories and change process (esp. for new authors)
- Review DCC report
- Approve NWI proposals?
- Incoming CPs ?
- Work items
- Prescription / Dispense
- Medication Record
- Catalog/Product discovery
10:30 - 12:00 Slot 1: Status and Project planning
Dedicated to planning and non-technical discussions
12:00-13:00 Lunch
13:00- 15:30 Work item planning
- Supply - ready for publication? CapabilityStatements?
- Catalog / Product discovery - align with IDMP and recent FHIR evolution
15:30- 16:00 Break
16:00- 17:30 E-Prescription
- Repositories and change process (esp. for new authors) (15 mins)
- Context and Impact:
- eP/eD process in Austria (Jürgen) + Gemini project
- ePrescription in Belgium (José)
- UNICOM and eHDSI prescription work and specifications (José, João, Rutt)
- Work on content
- Data models
- Cross-border / IDMP product model
- Actors and transactions